This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bioversys Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Julian Schill - Innovator in Pharmaceutical Formulations
Introduction
Julian Schill is an inventor based in Basel, Switzerland. He is currently associated with Bioversys AG, where he focuses on developing innovative pharmaceutical formulations. Although he has not yet been granted any patents, his work is significant in the field of drug formulation.
Latest Patent Applications
Julian Schill has submitted several notable patent applications. One of his latest applications is for an "Intravenous Rifabutin Formulation and Methods of Making." This invention provides compositions and methods for creating a rifabutin powder suitable for intravenous formulation preparation. Another application is for "3-(Phenylsulfonyl)-[1,2,3]Triazolo[1,5a]Quinazolin-5(4H)-One Derivatives." This invention relates to a compound with various chemical properties and potential applications in reducing the virulence of bacteria.
Conclusion
Julian Schill is an emerging inventor whose contributions to pharmaceutical formulations hold promise for future advancements in medicine. His innovative approaches may lead to significant improvements in treating bacterial infections.